 |
|
Breaking the 'mucus barrier' with a new drug delivery system
August 20, 2008Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus - regarded by many as nearly impenetrable - and carrying medication that could treat a range of diseases. Those conditions include lung cancer, cervical cancer and cystic fibrosis, the research noted in a presentation scheduled for the 236th National Meeting of the American Chemical Society.
"We studied the properties of disease-causing viruses that evolved to infect mucosal surfaces to engineer a coating that enables our drug delivery particles to penetrate mucus layers in minutes. In our new work, we have improved the coatings considerably to allow faster penetration for a wider array of particle sizes," says lead presenter Samuel K. Lai, Ph.D.
Mucus, the slippery secretion lining the lung airways, surface of the eye, gastrointestinal tract, and female reproductive tract, may seem delicate. But it is a tenacious barrier, effectively keeping out most pathogens and limiting infections.
"Mucus has evolved to be a highly efficient barrier," says Justin Hanes, professor of chemical & biomolecular engineering at Johns Hopkins University, the lead investigator of the study. "For example, we constantly inhale particles into our lungs, but they typically stick to mucus rather than penetrate it. Particles that stick are removed rapidly from the lungs on a mucus 'conveyor belt,' and are swallowed and sterilized in the gut. Mucus barriers protect us from constant infection, as well as everyday things like the millions of particles in the black cloud emitted from a bus when it takes off from a stop."
Unfortunately, mucus also prevents the passage of many beneficial drugs. And when the mucus gets thicker - most notably in diseases like chronic sinusitis, cystic fibrosis and chronic obstructive pulmonary disorder - drug treatment of the lungs and other mucus-lined areas becomes more difficult.
Lai explained that coating drug-loaded nanoparticles with an inexpensive polymer material allows particles to pass through the mucus linings. With this mucus-penetrating mechanism, drugs could be delivered locally and with enhanced durations to treat diseases at mucosal surfaces. In collaboration with Richard Cone, professor of biophysics at Johns Hopkins, the work also opens the door to more targeted drug delivery - including improved chemotherapy for cervical and lung cancer patients.
For inspiration in their quest to breech mucus, Hanes and colleagues took a lesson from Mother Nature - specifically viruses capable of infecting mucosal surfaces. Some of these viruses were able to pass through the dense, net-like mesh of mucus as if it were water.
The researchers found that the spaces between the "threads" of the mucus mesh were much larger than previously thought, providing an opportunity for drug particles that do not adhere to mucus to pass through and avoid rapid clearance .
"If a particle is small enough and not adhesive, then it can get through the mucus net - that's how some viruses penetrate mucus barriers," says Hanes.
The team found that a polymer known as polyethylene glycol, or PEG, could coat individual drug particles and imbue them with the same properties as these mucus-breeching viruses. "PEG is one of the most widely used polymers for therapeutic applications," Lai explains. It's an FDA approved polymer that's been in use in humans for over 25 years - it's known to be very safe."
By encapsulating drugs in mucus-penetrating particles, drug companies could expand the realm of treatment options for many diseases. "For example, cervical cancer patients could locally apply chemo drugs inside mucus-penetrating particles, which would then deliver the drug locally in the female reproductive tract at efficient concentrations over prolonged periods of time, instead of delivering it everywhere else in the body. That could drastically reduce the side effects as well as prolong the presence of drugs at the target site," says Lai.
And in the case of patients with cystic fibrosis -which causes thick mucus buildup in the lungs - mucus-penetrating drugs could create more effective therapies to fight the disease. This could improve the quality of life for 70,000 cystic fibrosis sufferers worldwide.
"Eventually, we seek to engineer systems where a drug could be delivered to a specific tissue or set of cells anywhere in the body - we want to make that possible."
American Chemical Society
"Mucus has evolved to be a highly efficient barrier," says Justin Hanes, professor of chemical & biomolecular engineering at Johns Hopkins University, the lead investigator of the study. "For example, we constantly inhale particles into our lungs, but they typically stick to mucus rather than penetrate it. Particles that stick are removed rapidly from the lungs on a mucus 'conveyor belt,' and are swallowed and sterilized in the gut. Mucus barriers protect us from constant infection, as well as everyday things like the millions of particles in the black cloud emitted from a bus when it takes off from a stop."
Unfortunately, mucus also prevents the passage of many beneficial drugs. And when the mucus gets thicker - most notably in diseases like chronic sinusitis, cystic fibrosis and chronic obstructive pulmonary disorder - drug treatment of the lungs and other mucus-lined areas becomes more difficult.
Lai explained that coating drug-loaded nanoparticles with an inexpensive polymer material allows particles to pass through the mucus linings. With this mucus-penetrating mechanism, drugs could be delivered locally and with enhanced durations to treat diseases at mucosal surfaces. In collaboration with Richard Cone, professor of biophysics at Johns Hopkins, the work also opens the door to more targeted drug delivery - including improved chemotherapy for cervical and lung cancer patients.
For inspiration in their quest to breech mucus, Hanes and colleagues took a lesson from Mother Nature - specifically viruses capable of infecting mucosal surfaces. Some of these viruses were able to pass through the dense, net-like mesh of mucus as if it were water.
The researchers found that the spaces between the "threads" of the mucus mesh were much larger than previously thought, providing an opportunity for drug particles that do not adhere to mucus to pass through and avoid rapid clearance .
"If a particle is small enough and not adhesive, then it can get through the mucus net - that's how some viruses penetrate mucus barriers," says Hanes.
The team found that a polymer known as polyethylene glycol, or PEG, could coat individual drug particles and imbue them with the same properties as these mucus-breeching viruses. "PEG is one of the most widely used polymers for therapeutic applications," Lai explains. It's an FDA approved polymer that's been in use in humans for over 25 years - it's known to be very safe."
By encapsulating drugs in mucus-penetrating particles, drug companies could expand the realm of treatment options for many diseases. "For example, cervical cancer patients could locally apply chemo drugs inside mucus-penetrating particles, which would then deliver the drug locally in the female reproductive tract at efficient concentrations over prolonged periods of time, instead of delivering it everywhere else in the body. That could drastically reduce the side effects as well as prolong the presence of drugs at the target site," says Lai.
And in the case of patients with cystic fibrosis -which causes thick mucus buildup in the lungs - mucus-penetrating drugs could create more effective therapies to fight the disease. This could improve the quality of life for 70,000 cystic fibrosis sufferers worldwide.
"Eventually, we seek to engineer systems where a drug could be delivered to a specific tissue or set of cells anywhere in the body - we want to make that possible."
American Chemical Society
Drug Delivery System Current Events and Drug Delivery System News RSSSelf-assembling nano-fiber gel delivers high concentrations of clinically approved drugs
Two teams of scientists from Harvard-MIT Division of Health Science and Technology (HST) at Brigham and Women's Hospital have developed a new self-assembling hydrogel drug delivery system that is biocompatible, efficient at drug release, and easy to tailor.
Biodegradable polymers show promise for improving treatment of acute inflammatory diseases
A family of biodegradable polymers called polyketals and their derivatives may improve treatment for such inflammatory illnesses as acute lung injury, acute liver failure and inflammatory bowel disease by delivering drugs, proteins and snips of ribonucleic acid to disease locations in the body.
Cancer drug delivery research at Case Western Reserve University cuts time from days to hours
Researchers at Case Western Reserve University have developed a technique that has the potential to deliver cancer-fighting drugs to diseased areas within hours, as opposed to the two days it currently takes for existing delivery systems.
Key Found to Breakthrough Drug for Clot Victims
A team of researchers at Oregon Health & Science University and Washington University in St. Louis have described for the first time the mechanism that gives a mutant enzyme molecule that they have engineered - and patented - the potential to become a breakthrough drug for treating heart attacks and strokes.
Developing a modular, nanoparticle drug delivery system
There are two aspects to creating an effective drug: finding a chemical compound that has the desired biological effect and minimal side-effects and then delivering it to the right place in the body for it to do its job.
Novel 3-D cell culture model shows selective tumor uptake of nanoparticles
A nanoparticle drug delivery system designed for brain tumor therapy has shown promising tumor cell selectivity in a novel cell culture model devised by University of Nottingham scientists.
UBC researcher finds new way to treat devastating fungal infections
Devastating blood-borne fungal infections that can be lethal for HIV/AIDS, cancer, and organ transplant patients may be treated more successfully, thanks to a new drug delivery method developed by researchers at the University of British Columbia in Vancouver.
Botulism study could lead to new vaccines and treatments to counter bioterrorist attacks
Of all the weapons in the bioterrorist arsenal, none is as potent as botulinum neurotoxin, which causes botulism-a potentially fatal disease with symptoms that include severe paralysis of the limbs and respiratory muscles.
A plastic pill for periodontal problems
Rutgers scientists today announced a revolutionary new treatment for killing the bacteria that attack gum tissue during periodontal disease, while also promoting healing and the regeneration of tissue and bone around the teeth.
The mind-body connection: how CNS regulates arthritis
In a unique approach to inflammation research, a study by researchers at the University of California, San Diego (UCSD) School of Medicine shows that, in a model of rheumatoid arthritis, inflammation in the joints can be sensed and modulated by the central nervous system (CNS).
More Drug Delivery System Current Events and Drug Delivery System News Articles
 | Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems by Loyd V Allen, Nicholas G Popovich, Howard C Ansel Long established as a core text for pharmaceutics courses, this book is the most comprehensive source on pharmaceutical dosage forms and drug delivery systems. Each chapter in this revised Eighth Edition includes two case studies—one clinical and one pharmaceutical. Content coincides with the CAPE, APhA, and NAPLEX competencies. This edition includes updated drug information and expanded... |
 | Liposome Drug Delivery Systems by Guru V. Betageri, Scott Allen Jenkins, Daniel Parsons Guide to current liposome drug delivery technology. Applications, preparation, pharmacokinetics, stability, passive and active targeting, and industrial production. Special emphasis on "stealth" liposomes - liposomes with extended circulation... |
 | Ophthalmic Drug Delivery Systems, Second Edition (Drugs and the Pharmaceutical Sciences) Extensively revised and updated, this second edition compares conventional and innovative drug delivery systems. The book covers significant ophthalmic advances and breakthroughs in gene therapy, ocular microdialysis, vitreous drug disposition modelling, and receptor/transporter targeted drug delivery. It examines procedures in pharmacokinetic/pharmacodynamic modeling for the determination of... |
 | Gibaldi's Drug Delivery Systems in Pharmaceutical Care by Archana Desai and Mary Lee Gibaldi's Drug Delivery Systems in Pharmaceutical Care, an innovative new textbook, demonstrates how the modern clinical pharmacist can integrate knowledge in pharmaceutical sciences and therapeutics with appreciation of patient-specific factors to best meet patient needs. This text seeks to make therapeutics a critical component of teaching about dosage forms and to make dosage forms and... |
 | Design of Controlled Release Drug Delivery Systems (McGraw-Hill Chemical Engineering) by Xiaoling Li The goal of every drug delivery system is to deliver the precise amount of a drug at a pre-programmed rate to the desired location in order to achieve the drug level necessary for the treatment. An essential guide for biomedical engineers and pharmaceutical designers, this resource combines physicochemical principles with physiological processes to facilitate the design of systems that will... |
 | Drug Delivery Systems (Methods in Molecular Biology) The field of drug development and therapeutics can be overwhelmingly encyclopedic and vast. In Drug Delivery Systems, Dr. Kewal Jain and a team of experts select the most important, cutting-edge technologies used in drug delivery systems taking into account significant drugs, new technologies such as nanoparticles, and therapeutic applications. The chapters present step-by-step laboratory... |
 | Nanoparticulate Drug Delivery Systems (Drugs and the Pharmaceutical Sciences) Since the advent of analytical techniques and capabilities to measure particle sizes in nanometer ranges, there has been tremendous interest in the use of nanoparticles for more efficient methods of drug delivery. This expertly written guide addresses the scientific methodologies, formulation, processing, applications, recent trends, and emerging technologies in the research of nanoparticulate... |
 | Biodegradable Polymers as Drug Delivery Systems (Drugs and the Pharmaceutical Sciences) by Mark Chasin, Robert Langer Reviews the properties, synthesis, and formulations of a number of well studied polymers increasingly being used in site-specific or systematic administration of pharmaceutical agents. For each of the polymers, discusses the background; chemistry and synthesis; the formulation of microcapsules,... |
 | Specialized Drug Delivery Systems (Drugs and the Pharmaceutical Sciences) |
| Drug Delivery Systems: Fundamentals and Techniques (Ellis Horwood Series in Biomedicine) by P. Johnson Seventeen articles survey from a multidisciplinary perspective site-specific, implantable, oral, and other non-invasive drug delivery systems. The chapters are based on up-to-date information and in several cases form comprehensive reviews of current progress in the field with appropriate glimpses into the... |
| © 2008 BrightSurf.com |